3
views
0
recommends
+1 Recommend
0 collections
    0
    shares
      • Record: found
      • Abstract: found
      • Article: not found

      Indoxyl sulfate upregulates prorenin expression via nuclear factor-κB p65, signal transducer and activator of transcription 3, and reactive oxygen species in proximal tubular cells.

      Read this article at

      ScienceOpenPublisherPubMed
      Bookmark
          There is no author summary for this article yet. Authors can add summaries to their articles on ScienceOpen to make them more accessible to a non-specialist audience.

          Abstract

          We have recently found that indoxyl sulfate induces prorenin expression in proximal tubular cells. The present study aimed to determine whether nuclear factor-κB (NF-κB) p65, signal transducer and activator of transcription 3 (Stat3), and reactive oxygen species are involved in indoxyl sulfate-induced prorenin expression in cultured human proximal tubular cells (HK-2 cells). Effects of indoxyl sulfate on prorenin expression were determined using HK-2 cells with small interfering RNAs (siRNAs) specific to NF-κB p65 and Stat3, N-acetylcysteine, an antioxidant, and diphenyleneiodonium, an inhibitor of nicotinamide adenine dinucleotide phosphate oxidase. Indoxyl sulfate increased prorenin expression in HK-2 cells. siRNAs specific to NF-κB p65 and Stat3 inhibited indoxyl sulfate-induced prorenin expression. Both N-acetylcysteine and diphenyleneiodonium suppressed indoxyl sulfate-induced prorenin expression. Indoxyl sulfate upregulates the expression of prorenin via NF-κB p65, Stat3, and reactive oxygen species in proximal tubular cells.

          Related collections

          Author and article information

          Journal
          J Ren Nutr
          Journal of renal nutrition : the official journal of the Council on Renal Nutrition of the National Kidney Foundation
          Elsevier BV
          1532-8503
          1051-2276
          Mar 2015
          : 25
          : 2
          Affiliations
          [1 ] Department of Advanced Medicine for Uremia, Nagoya University Graduate School of Medicine, Nagoya, Japan.
          [2 ] Department of Advanced Medicine for Uremia, Nagoya University Graduate School of Medicine, Nagoya, Japan; Division of Nephrology, Department of Internal Medicine, Kaohsiung Chang Gung Memorial Hospital and Chang Gung University College of Medicine, Kaohsiung, Taiwan.
          [3 ] Department of Advanced Medicine for Uremia, Nagoya University Graduate School of Medicine, Nagoya, Japan; Faculty of Health and Nutrition, Shubun University, Ichinomiya, Aichi, Japan. Electronic address: tniwa@med.nagoya-u.ac.jp.
          Article
          S1051-2276(14)00205-2
          10.1053/j.jrn.2014.10.008
          25556305
          578ac4f3-8153-421e-a917-15e76ab908ed
          History

          Comments

          Comment on this article